DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions
- PMID: 16949934
- DOI: 10.1016/j.humpath.2006.04.025
DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions
Abstract
Monoclonal adrenocortical lesions show inverse correlation between proliferation and apoptosis, with proliferation being the single most important criterion of malignancy in adrenal lesions. No study yet has evaluated the variability of proliferation regarding the clonal pattern and diagnosis in adrenocortical nodular hyperplasias (ACNHs), adrenocortical adenomas (ACAs), and adrenocortical carcinomas (ACCs). We studied 69 ACNHs, 64 ACAs, and 23 ACCs (World Health Organization criteria) from 156 females. Clonality HUMARA test (from microdissected DNA samples), DNA content and proliferation analysis (slide and flow cytometry), and mitotic figure (MF) counting/50 high-power fields (HPFs) were performed in the same areas. Heterogeneity was assessed by 5cER (percentage of nonoctaploid cells with DNA content exceeding 5c) and standard deviation of MF/HPF. Statistics included analysis of variance/Student t tests regarding the clonal patterns and diagnosis. Polyclonal patterns were observed in 48 of 62 informative ACNHs and 7 of 56 informative ACAs, and monoclonal in 14 of 62 ACNHs, 49 of 56 ACAs, and 21 of 21 ACCs, with all hyperdiploid lesions (14 ACCs and 13 ACAs) being monoclonal. The standard deviation of MF/HPF progressively increased in ACNH-ACA-ACC (0.048 +/- 0.076, 0.110 +/- 0.097, 0.506 +/- 0.291, respectively; P = .0023), but did not differentiate ACNH/ACA. Only tetraploid percentage (P = .0496) and 5cER (P = .0352) distinguished polyclonal (3.64 +/- 2.20 and 0.14 +/- 0.15) from monoclonal (7.25 +/- 7.52 and 1.00 +/- 1.74) benign lesions. Malignancy significantly correlated with a low diploid percentage and high tetraploid percentage. Cell kinetic heterogeneity is the hallmark of adrenocortical neoplasms: tetraploid/hypertetraploid cell accumulation characterizes monoclonal lesions (suggesting nondisjunctional mitoses), whereas heterogeneously distributed mitotic figures and decreased diploid percentage define ACCs.
Similar articles
-
Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.Hum Pathol. 2001 Nov;32(11):1232-9. doi: 10.1053/hupa.2001.28949. Hum Pathol. 2001. PMID: 11727263
-
Clonality as expression of distinctive cell kinetics patterns in nodular hyperplasias and adenomas of the adrenal cortex.Am J Pathol. 2000 Jan;156(1):311-9. doi: 10.1016/S0002-9440(10)64732-3. Am J Pathol. 2000. PMID: 10623680 Free PMC article.
-
Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.Endocr Relat Cancer. 2009 Jun;16(2):573-83. doi: 10.1677/ERC-08-0237. Epub 2009 Feb 13. Endocr Relat Cancer. 2009. PMID: 19218281
-
Molecular markers and the pathogenesis of adrenocortical cancer.Oncologist. 2008 May;13(5):548-61. doi: 10.1634/theoncologist.2007-0243. Oncologist. 2008. PMID: 18515740 Review.
-
The molecular basis of adrenocortical cancer.Cancer Genet. 2012 Apr;205(4):131-7. doi: 10.1016/j.cancergen.2012.02.009. Cancer Genet. 2012. PMID: 22559973 Review.
Cited by
-
Clinical implications of intratumor heterogeneity: challenges and opportunities.J Mol Med (Berl). 2020 Feb;98(2):161-177. doi: 10.1007/s00109-020-01874-2. Epub 2020 Jan 22. J Mol Med (Berl). 2020. PMID: 31970428 Free PMC article. Review.
-
Review paper: origin and molecular pathology of adrenocortical neoplasms.Vet Pathol. 2009 Mar;46(2):194-210. doi: 10.1354/vp.46-2-194. Vet Pathol. 2009. PMID: 19261630 Free PMC article. Review.
-
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.Endocr Relat Cancer. 2015 Dec;22(6):953-67. doi: 10.1530/ERC-15-0086. Epub 2015 Sep 23. Endocr Relat Cancer. 2015. PMID: 26400872 Free PMC article.
-
Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design.Int J Mol Sci. 2012;13(2):1951-2011. doi: 10.3390/ijms13021951. Epub 2012 Feb 13. Int J Mol Sci. 2012. PMID: 22408433 Free PMC article. Review.
-
Pathological bases for a robust application of cancer molecular classification.Int J Mol Sci. 2015 Apr 17;16(4):8655-75. doi: 10.3390/ijms16048655. Int J Mol Sci. 2015. PMID: 25898411 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources